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Abstract
Background: The greatest challenge facing expanded programs on immunization in general, and
in Burkina Faso in particular, lies in their capacity to achieve and sustain levels of immunization
coverage that will ensure effective protection of children.This article aims to demonstrate that full
immunization coverage of children, which is the primary indicator for monitoring national
immunization programs, is sufficient neither to evaluate their performance adequately, nor to help
identify the broad strategies that must be implemented to improve their performance. Other
dimensions of performance, notably adherence to the vaccination schedule and the efficacy of the
approaches used to reach all the children (targeting) must also be considered.
Methods:The study was carried out using data from surveys carried out in Burkina Faso:the 1993,
1998 and 2003 Demographic and Health Surveys and the 2003 national Survey of Immunization
Coverage. Essentially, we described levels of immunization coverage and their trends according to
the indicators considered. Performance differences are illustrated by amplitudes and
maximum/minimum ratios.
Results: The health regions’ performances vary according to whether they are evaluated on the
basis of full immunization coverage or vaccination status of children who have not completed their
vaccinations.The health regions encompass a variety of realities,and efforts of substantially different
intensity would be required to reach all the target populations.
Conclusions: Decision-making can be improved by integrating a tripartite view of performance
that includes full immunization coverage,adherence to the vaccination schedule (timely coverage),
Open AccessAbstract in French
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Background
Substantial efforts have been made by sub-Saharan
African countries to reinforce their immunization pro-
grams. One of the major challenges facing immunization
services is to achieve and sustain the high levels of per-
formance necessary for complete and appropriate
coverage of target populations [1–3]. Usually, the moni-
toring of immunization services performance is done by
compiling and analyzing indicators of completeness.
These show the extent to which immunization programs
were able to vaccinate targeted children against the entire
group of antigens targeted by the Expanded Program on
Immunization (EPI): BCG, diphtheria, tetanus, pertussis,
poliomyelitis, measles, and yellow fever. The measures
generally used indicate the proportion of children who
are fully vaccinated (full immunization coverage (FIC)) or
vaccinated for specific antigens (particularly DTCP3)
[4,5]. This process is restrictive, however, in that it only
takes into account the number of vaccines received, but
not the age of the child at the time of vaccination and the
adherence to the vaccination schedule. The use of FIC as
an indicator of the effectiveness of immunization pro-
grams leads to categorizing targeted children into two
groups: those fully vaccinated and those not fully vacci-
nated. This dichotomy has the advantage of simplicity,
but it oversimplifies the reality, which is that both cate-
gories include a broad spectrum of different situations in
terms of vaccination efficacy and adequacy. It results, for
example, in children who are fully vaccinated being con-
sidered “successes” whether or not the vaccination
schedule was adequately respected. This group thus
includes children vaccinated too late or too early, whose
chances of being really immunized are thereby limited.
When all is said and done, the homogeneity of the “fully
vaccinated” group of children is only ostensible, and
health regions that are considered to be high-performing
in terms of coverage may actually be performing at a
mediocre level if we take into account the children’s age at
vaccination and the degree to which the vaccination
schedules of the target populations were respected. This is
confirmed by several studies carried out in sub-Saharan
Africa. In Malawi, a recent study shows that while 93% of
children had received their third dose of DTC by the age
of 23 months, only 2% had received it at the recom-
mended age of 14 weeks, and 49% at six months [6]. The
same trend is seen with both BCG (95% coverage at 15
months, only 22% at one week and 53% at six weeks) and
measles. In the Central African Republic, Kahn et al.
reported a pattern of late vaccination for measles [7]. They
calculated that vaccinated children who had an opportu-
nity for earlier vaccination were, on average, exposed to 70
“days-at-risk of measles” (age at vaccination in days
minus 270, which is the recommended age for vaccina-
tion). In rural areas, the average delay was more than
three months (98 days). Other studies mention vaccina-
tions that are too early. A survey in Mozambique reports
that among all children who had received all required
vaccines, one out of 10 had received the measles vaccine
before 8.5 months of age [8]. In the previously mentioned
study in Malawi, 17% were vaccinated against measles
before nine months of age.
In addition, this dichotomy does not take into account
possible disparities in vaccination status among the group
of children considered not fully vaccinated. It obscures
the fact that some children in this group have received no
vaccine at all, while others are missing only one or two, to
have full coverage. Thus, regions with good FIC perform-
ance can show poor performance in their capacity to
improve this indicator, since the proportions are high of
children with no vaccine and those missing one or two.
Therefore, analyzing the outcomes of immunization
activities and evaluating program performance require
using an array of indicators that take into consideration
both quantitative (ability to reach targeted children) and
qualitative (respecting the vaccination schedule for chil-
dren reached in the targeted population) dimensions of
vaccination. 
In this article, we propose an approach to performance
analysis based on the efficacy of the targeting of children
to be vaccinated. Appropriate targeting is defined by the
EPI’s capacity, on the one hand, to reach the targeted chil-
dren, and on the other, to vaccinate those children in
accordance with the vaccination schedule. We intend to
show that such an approach, simple in its application and
requiring no particular skills of analysis, makes it possible
to go beyond the general indications provided by the
rough indicators of coverage and obtain a truer picture of
the real immunization activities in regions or health
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and the status of children who are not fully vaccinated.With such an approach, interventions can
be better targeted. It provides information on the quality and timeliness of vaccination and
identifies the efforts required to meet the objectives of full immunization coverage.
Abstract in French: See the full article online for a translation of this abstract in French.districts. It offers the potential to uncover territorial enti-
ties whose actual poor performance is masked by levels of
gross immunization coverage that appear satisfactory,
and, in so doing, contributes more effectively to the devel-
opment of strategic orientations. However, in this paper,
which is essentially focused on the development and uti-
lization of more precise performance indicators for
vaccination programs, we will not deal with the reasons
underlying why vaccination schedules are not respected
and coverage is adequate or inadequate. The reader inter-
ested in these issues may consult the scant literature on
this topic, particularly the studies of Jahn in Malawi [6].
Methods
Sources of data 
The data we used were taken from three Demographic
and Health Surveys (DHS) —1993, 1998, 2003 — and
the Immunization Coverage Survey (ICS) carried out in
2003 at the level of health districts in Burkina Faso. The
DHS is a national survey carried out using a standardized
methodology [9–11]. The surveys of 1993 and 1998 used
a division of the country into five economic regions while
that of 2003 was based on the country being divided into
13 administrative regions that correspond also to the
health regions. The samples of the three surveys are briefly
described in Table 1.
The ICS was based on the cluster method developed by
WHO [12,13]. Each cluster consists of at least seven chil-
dren between the ages of 12 and 23 months and seven
mothers of babies from 0 to 11 months of age. The sam-
pling frame was the population of each health district: 30
clusters were selected per health district, and thus, at the
national level, there were 1560 clusters. Sampling took
into account the demographic importance of the villages
and the sectors of communes, thereby ensuring good pro-
portional representation. The identification of clusters
was done using COSAS software and the National Health
Information System file of the Direction des études et de
la Planification. In each cluster selected, the seven chil-
dren are identified in households by moving from one
relation to another, extending outward from a central
point.
Vaccination schedule, evaluation criteria
The vaccination schedule used in Burkina Faso during the
period covered by the three DHSs and the ICS is present-
ed in Table 2. The immunization coverage rates that are
considered in the DHSs and the ICS are estimated from
the children’s health booklets presented by the mothers
or, for the BCG vaccine, from the surveyor’s direct obser-
vation of a scar. A child’s coverage is considered to be
complete if he has received one dose of BCG, three of
DTP, one of measles vaccine, and one of yellow fever vac-
cine. The child is considered to have been correctly
vaccinated (timely vaccination) if the minimum interval
between two doses of DTP is 28 days and if the child was
vaccinated for measles and yellow fever no sooner than
255 days after birth.
Analysis
Full immunization coverage is the primary indicator used
to illustrate EPI performance (at the national and region-
al levels) and its evolution over the three periods (1993,
1998, and 2003). The second indicator is timely coverage.
We used two scenarios for timely coverage in order to bet-
ter assess the requirements entailed by adherence to the
vaccination schedule. For a child to be considered cor-
rectly vaccinated, fixed time intervals were set for
administration of the DTCP and the measles vaccines, as
well as the yellow fever vaccine. Thus, in the first scenario
we consider the vaccination to be timely if the interval
between the first and third doses of DTCP is less than 60
days, and if the vaccine for measles and yellow fever is
administered no sooner than 255 days and no later than
360 days after birth. The second scenario is less conserva-
tive: we consider vaccination to be timely if the interval
between the first and third doses of DTCP is less than or
equal to 90 days, with the same requirements as above for
the measles and yellow fever vaccines. Comparative analy-
sis of the evolution of the FIC and of timely coverage is
carried out at the regional level for 1993 and 1998.
Finally, to compare the performances of the health
regions, we use a third group of three indicators that
describe the vaccination status of children who have not
completed their vaccinations: percentages of children
who have received no vaccine, have missed only one, or
have missed two vaccinations on the schedule.
Results
The estimate of FIC for 2003 provided by the ICS is
52.2%, with quite substantial regional variations. The
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Table 1 - Demographic and Health Surveys (DHS) in Burkina Faso:
Sample and territorial representation.
Year Territorial representation Sample (n)
1993 5 economic regions 1104
1998 5 economic regions 1041
2003  13 health regions 1840
Table 2 - Burkina Faso: Vaccination schedule.
Contacts Age at vaccination  Recommended antigens
1 Birth BCG, polio 0
2 2 months DTCP1, polio 1
3 3 months DTCP2, polio 2
4 4 months DTCP3, polio 3
5 9 months Measles, yellow-fever vaccinesestimates provided by the DHSs are more conservative
and reveal a positive progression of immunization cover-
age in the period 1998-2003 (Table 3). All the rough
indicators of coverage converge and indicate an increase
in coverage for the various antigens, a decrease in children
lost to follow-up of BCG/DTCP1 and DTCP1/DTCP2, and
a relative reduction in regional disparities. However, the
picture presented by the rough indicators of coverage is
much less impressive once the quality of the targeting is
taken into account. Even the least conservative scenario
reveals a disturbing situation. With barely one child out
of five having been correctly and appropriately vaccinated
in 2003 and, among those fully vaccinated, scarcely one
out of two having been vaccinated in accordance with the
norms of the vaccination schedule, population coverage
and national EPI performance remain limited.
The current discrepancy between complete coverage and
timely coverage is largely due to the late vaccination of
children, as shown in Figures 1a to 1e. Thus, in 2003,
fewer than half (42.5%) of the children vaccinated with
BCG received it in their first month of life (Figure 1a),
and 18% had received it after the age of three months
(Figure 1b). More than one-third (36%) of vaccinated
children had received their third dose of DTCP after the
age of six months, and 20% after the age of nine months
(Figures 1e, 1f). Finally, only 7% of children vaccinated
against measles were vaccinated at the age of nine
months; 5% were vaccinated before nine months, 65%
between months 10 and 12, and 17.4% at 13 months
and over (Figures 1c, 1d). However, the six figures show
— and it is here that we see the value of the indicators
used — that the quality of targeting of children improved
significantly between 1998 and 2003 for each of the
three vaccinations (Table 4). In the case of BCG, for
example, children are vaccinated earlier and earlier, and
the vaccination schedule is better respected. The low rates
of coverage in assisted deliveries in health facilities part-
ly explain why half the children receive their BCG vaccine
late, at the age of one month. The situation is also
improving for measles and DTCP3.
Table 5 presents the performance, in terms of immuniza-
tion coverage, of the country’s five large territories in 1993
and 1998 (comparable data are unfortunately not avail-
able for 2003 because of the administrative
reconfiguration of the regions). Whatever indicator is
used, the performances of the regions vary considerably.
The central region, which includes the urban region of the
capital, presents levels of performance significantly high-
er than the others (Table 5). In every case, the proportion
of children who are correctly vaccinated appears low,
regardless of the region, although there has been a ten-
dency toward improvement over the years. The
performances of the regions are better if we consider the
longer intervals between the first and third doses of DTCP,
which reflect the tendency to vaccinate somewhat later
those children who have already received their first dose
of DTCP. The administrative reports we consulted suggest
that this will be repeated in 2003 [12], but always with the
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Table 3 - Vaccination coverage in Burkina Faso 1993–2003.
Source of information
Indicator ICS2003 DHS2003 DHS1998 DHS1993
National immunization coverage 
FIC (full immunization coverage) 52.1 44.0 28.8 34.0
BCG 90.3 81.0 72.6 86.3
DTCP3 77.0 57.0 41.3 40.6
Measles 71.6 56.0 49.0 61.1
Regional disparities in immunization coverage (FIC)
Region with lowest FIC 31.0 33.1 7.1 –
Region with highest FIC 72.0 61.6 37.7 –
Ratio Max /Min 2.3 1.9 5.3 –
Rate of loss to follow-up 
DTCP1/DTCP3 – 18.3 31.6 48.3
BCG/DTCP3 – 21.2 39.1 52.3
Appropriateness of targeting
DTCP1: children vaccinated before their 3rd month of life – 47.9 37.6 28.2
DTCP3: children vaccinated before their 5th month of life – 27.5 22.5 18.8
Measles: children vaccinated between the 9th and 12th months of life – 73.5 67.8 67.4
Children correctly vaccinated among those completely vaccinated – Scenario 1 – 36.2 27.8 26.6
Children correctly vaccinated among those completely vaccinated – Scenario 2 – 55.5 46.8 45.6
Children completely and correctly vaccinated – Scenario 1 – 14.1 7.3 7.9
Children completely and correctly vaccinated – Scenario 2 – 21.5 12.2 13.6
*Children who received the first vaccination cited, but not the second.considerable disparity between the central region and the
rest of the country.
It is interesting to note that the regions where FIC is great-
est are also those where the vaccination schedule is
generally better respected, and inversely (Figure 2), in
both urban and rural areas. One exception to this is in the
East region. As with FIC, the proportion of children cor-
rectly vaccinated in the rural area is considerably lower
than in the urban area. In both areas, there was significant
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Figure 1 - Age of children at vaccination and cumulative coverage by age: BCG, Measles, DTCP3 – 1993, 1998
and 2003.improvement between 1993 and 2003. The fact that both
FIC and timely coverage are moving in the same direction
is an encouraging sign (Figure 2).
Table 6 presents regional performance with respect to the
vaccination status of children who had not yet completed
their vaccinations in 2003 (source: ICS). A first group con-
sists of three health regions where a high proportion
(more than 40%) of children with incomplete vaccina-
tion actually had no vaccinations at all. These are the
regions of Hauts-Bassins, Plateau-Central, and Sahel. In
other words, in these regions there are still enormous
needs among the population of children whose vaccina-
tions are incomplete. A second group is made up of
regions in which a high proportion of children with
incomplete vaccinations have missed only one. While
coverage of these children is incomplete, most of them
have completed two of the three required vaccination
sequences and would need only one complementary
vaccine to be completely covered. These regions are the
North, Center-West, Center, and Boucle du Mouhoun.
The six other regions are in an intermediate position. The
children who are not completely vaccinated are distrib-
uted relatively evenly among those having received no
vaccines, those missing one, and those missing two. These
three groupings convey not only different levels of per-
formance among the health regions, but also situations
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Table 5 - Vaccination coverage by large regional groupings in 1993 and 1998.
1993 1998
Timely coverage Timely coverage
Region Gross coverage (FIC) Scenario 1 Scenario 2 Gross coverage (FIC) Scenario 1 Scenario 2
Center 60.4 29.4 43.5 69.1 38.2 51.8
North 11.4 2.2 2.7 20.3 4.1 10.1
East 32.1 5.7 13.4 23.1 7.2 9.5
West 32.3 6.0 11.4 19.2 2.9 4.5
Center-South 27.9 8.1 13.4 33.1 7.0 15.2
Scenario 1: Children completely and correctly vaccinated (measles at 9-12 months and DTCP 1-3 intervals of ≤2 months).
Scenario 2: Children completely and correctly vaccinated (measles at 9-12 months and DTCP 1-3 intervals of ≤3 months).
Source: DHS 1993, 1998.











93 98 93 98 93 98 93 98 93 98 93 03 93 03
Center North East West  Center
South
Urban Rural
Region                           Area
Performance (%)
Full immunization coverage (FIC) 
Correct vaccination (timely)  – Scenario 2 (less conservative) 
Correct vaccination (timely)  – Scenario 1 (conservative) 
Table 4 - Age (months) at vaccination of children for BCG, measles and
DTCP.
Year 1993 1998 2003
BCG
Total vaccination coverage (%) 70.0 49.4 59.5
Mean age at vaccination 2.6 2.3 1.5
Median age at vaccination 1.0 1.0 1.0
Standard deviation 3.9 3.4 2.4
Measles
Vaccination coverage 50.9 35.3 45.4
Mean age at vaccination 11.4 10.8 10.3
Median age at vaccination 11.0 10.0 10.0
Standard deviation 3.2 3.1 2.5
DTCP1
Vaccination coverage 66.8 45.7 59.8
Mean age at vaccination 4.8 4.5 3.5
Median age at vaccination  3.0 3.0 3.0
Standard deviation 3.8 3.8 2.9
DTCP2
Vaccination coverage 55.8 39.1 55.3
Mean age at vaccination 7.1 6.2 5.2
Median age at vaccination  6.0 5.0 4.0
Standard deviation 4.0 3.8 3.1
DTCP3
Vaccination coverage 34.4 31.7 48.9
Mean age at vaccination 8.0 7.5 6.6
Median age at vaccination  7.0 6.0 6.0
Standard deviation 4.2 3.8 3.2
Source: DHS 1993, 1998, 2003.that will require efforts of varying levels of intensity to
achieve the goals of complete coverage and to address the
unmet needs of target populations effectively. 
The regions’ performances are different depending on
whether we are looking at the level of FIC or the vaccina-
tion status of children who have not completed their
vaccinations. Some regions perform well in terms of the
former, but not the latter (notably Center-East and Center-
South). Conversely, some regions have poor FIC
performance, but a major part of their incomplete vaccina-
tions consists of children who have missed only one
vaccine. Thus, for example, the Boucle du Mouhoun region
ranks nine out of 13 in terms of FIC, but with respect to
children with incomplete vaccination, it has the lowest pro-
portion of children who have never had a vaccine.
Discussion
Numerous efforts have been made over recent decades to
broaden the availability of vaccination services in Burkina
Faso, such as a policy to achieve autonomy in vaccination
by purchasing vaccines through the national budget, and
extension of service coverage [12]. This article proposes a
simple and practical approach to help decision makers
assess EPI performance and progress, in order to identify
high-priority and more specific needs for intervention. 
The most commonly used indicator, FIC, allows for the
evaluation, up to a certain point, of national EPI perform-
ance and its progress and of disparities among health
regions. However, as we have seen, this indicator does not
take into account the heterogeneity of situations encoun-
tered related to respecting the vaccination schedule, and
particularly to delays in the administration of one or sever-
al vaccines. Little is known about the population impacts of
these incorrect vaccinations on the outcomes of vaccina-
tion programs, which will need to be better documented.
However, they may be greater than expected. In Germany,
Siedler et al., found that “50% of measles cases in 1-year
old children would be prevented if presently observed vac-
cine coverage rates in the third year of life could be
achieved 12 months earlier” [14]. A delay in the adminis-
tration of one vaccine could not only increase the child’s
vulnerability to the antigen concerned, but also weaken
adherence to subsequent vaccination [15] and thereby
increase the risk that the child will never complete the vac-
cination course [16]. Finally, a high level of incorrect
vaccinations could significantly affect these programs’ abil-
ity to lower vaccine-preventable mortality. In Bangladesh,
Brieman et al. showed that children vaccinated with BCG
before the age of six months are at considerably lower risk
of dying in the first five years of life than are children vac-
cinated later (hazard rate: 0.47-0.73) [17]. 
Thus, timeliness of vaccine coverage complements the
information provided by FIC. It offers a more precise ren-
dering of EPI efficacy, provides more plausible measures of
the actual immunization of target populations and there-
by offers better information on the quality of processes.
Where targeting is perfect, these two indicators coincide.
However, this is far from the case in Burkina Faso, where it
seems the priority issues are related as much to improving
vaccination processes as to extending coverage. It is never-
theless interesting to note that there is a fair amount of
concordance between the level of gross coverage and the
quality of processes as indicated by the measurement of
timely coverage (Table 5). With only one exception, this
concordance is also observed in the progress of perform-
ances among the health regions at the disaggregate level.
Examining the vaccination status of children who are not
fully vaccinated allows us to refine the EPI performance
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Table 6 - Vaccination status of children with incomplete coverage by health region.
Children not completely covered  Distribution of children whose vaccinations are incomplete (%)
Region N % No vaccination Missing one vaccination Missing two vaccinations
Hauts-Bassins 159 62 47 25 28
Plateau Central 56 55 46 31 23
Sahel 108 77 42 35 23
East 73 56 37 30 33
Cascades 32 48 35 24 41
Center-East 88 56 30 27 43
Center-North 77 41 29 30 41
Center-South 44 48 26 34 40
South-West 41 47 25 24 51
North 148 72 23 44 33
Center-West 75 64 22 30 48
Center 50 37 13 60 27
Boucle du Mouhoun 80 50 11 48 41
TOTAL 1031 100 31 34 35
Source: DHS 2003.analysis and to determine more precisely both the scope of
the needs to be addressed and the interventions required to
achieve complete and timely coverage. At the national level,
31% of children who are not fully vaccinated have received
no vaccine at all, which means that nearly one-third of
non-vaccinated children have had no contact with immu-
nization services. At the regional level, the high proportion
of children having had no vaccine among those not fully
vaccinated represents a problem of inadequate immuniza-
tion strategies. The effort required to respond to the needs
of these children is substantial. Why are so many children
never reached? To what extent are these children concen-
trated in populations that are poor, far from points of
service, or vulnerable, and also, to what extent do these
children lost to follow-up reflect existing health inequities?
More detailed analysis of local strategies would help in
understanding the reasons and the systemic deficiencies at
play. Conversely, in the regions where the proportion of
children who have received no vaccine is low, the problem
has less to do with the appropriateness of the overall strat-
egy and the quality of the processes for reaching targeted
children, than with the capacity of the services in place to
guarantee the completeness of the vaccinations carried out.
Our results show that, in the regions, the level of com-
plete coverage is poorly correlated with the proportion of
children not vaccinated at all, and consequently, it is not
very useful for estimating the scope of work to be carried
out (Table 7). Comparing the ratings of the regions on the
basis of the three performance criteria we used reveals not
only their complementarity, but also the limitations of
any analysis of coverage that is focused exclusively on
complete coverage. Some regions that rate well on the FIC
criterion are in a lower position when it comes to the pro-
portion of children who received no vaccine at all.
Conversely, the ratings of regions such as the North,
Center-West, and Boucle du Mouhoun improve when we
move from FIC to children with no vaccine. Finally, some
regions such as Hauts-Bassins, Sahel, and South-West
have relatively stable ratings.
These results indicate that, in analyzing EPI performance,
taking into consideration both FIC and targeting will pro-
vide better vantage points from which decisions can be
taken to improve the situation. In certain regions such as
Sahel, Hauts-Bassins, and Plateau-Central, not only is FIC
low, but the outlook for improvement is poor because of
the inadequate strategies in place. In the Center-North,
Center-East, and East regions, the current inadequacy of
the immunization strategies will eventually make it
difficult to improve complete coverage which is, for the
moment, relatively good. On the other hand, in the
regions of Boucle du Mouhoun, North, and Center-West,
the results suggest that the current low level of FIC could
be improved quite significantly by placing greater empha-
sis on improving the efficacy of current strategies for
completing vaccinations.
Conclusions 
The goal of the EPI is to achieve a significant reduction in
vaccine-preventable diseases. From this perspective, the
national objective is to ensure complete and timely
immunization coverage for 80% of targeted children
[12]. In recent decades, substantial progress has been
made in immunization coverage. To sustain this trend,
more precise information is needed on EPI performance.
The results of the present study indicate that decision-
making can be improved by integrating a tripartite view of
performance that includes FIC, adherence to the vaccina-
tion schedule (timely coverage), and the status of children
who are not completely vaccinated. Using such an
approach, interventions can be better targeted and help to
reduce inequities in health care and access to vaccination.
In effect, combined analysis of these three dimensions at
the district, regional, and national levels enables us to
identify more clearly the extent to which children have
received all the doses of vaccines, and the extent to which
these doses respected the vaccination schedule, as well
as the exact status of those who did not receive all the
doses. At this time, there are studies [18–22] that have
documented the various determinants of the elements
of this performance, notably with respect to adherence
to the vaccination schedule and full immunization cov-
erage. More detailed studies should make it possible to
better understand the reasons underlying the perform-
ance deficiencies encountered.
List of abbreviations used
DHS – Demographic and Health Survey; EPI – Expanded
Program on Immunization; FCI – Full immunization cov-
erage; ICS – Immunization Coverage Survey.
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Table 7 - Ratings of health regions according to three performance criteria.
Rating
Proportion of 
children with Level of 
Region Level of FIC no vaccine timely coverage
Center 1 2 2
Center-North 2 7 3
Center-South 3 6 1
Center-East 4 8 4
South-West 5 5 12
East 6 10 6
Cascades 7 9 8
Plateau Central 8 12 11
Boucle du Mouhoun 9 1 10
Hauts-Bassins 10 13 7
Center-West 11 3 9
North 12 4 5
Sahel 13 11 13Competing interests
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